Earth Science Tech's Q1 net income, revenue rise
Earth Science Tech's Q1 net income, revenue rise
Overview
US health and wellness holding firm's fiscal Q1 revenue grew yr/yr
Net income for fiscal Q1 rose 57%, with diluted EPS more than tripling yr/yr
Company repurchased and retired 3.7 mln shares, up from 505,000 a year ago
Outlook
Company is focused on expanding geographic footprint and advancing telehealth and pharmacy fulfillment platforms
Company is evaluating strategic opportunities to broaden into new, complementary verticals
Result Drivers
PHARMACY EXPANSION - Compounding pharmacy operations continued to expand licensing footprint across the US
OPERATIONAL EFFICIENCY - Co attributed improved profitability to operating leverage and greater efficiencies
Company press release: ID:nGNX7D55Ls
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Revenue |
| $9 mln |
|
Reuters Recommended Reads
Aug 6 - Guardian Pharmacy Q2 revenue beats estimates; 2026 outlook lifted
Aug 5 - GoodRx Q2 revenue beats estimates; raises 2026 outlook
Aug 5 - LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)